Overview: This page contains the latest trade data of Insulin, in dosage. In 2019, Insulin, in dosage were the world's 301st most traded product, with a total trade of $10.2B. Between 2018 and 2019 the exports of Insulin, in dosage grew by 0.56%, from $10.1B to $10.2B. Trade in Insulin, in dosage represent 0.056% of total world trade.
Exports: In 2019 the top exporters of Insulin, in dosage were Germany ($2.96B), Denmark ($2.49B), France ($2.15B), Italy ($787M), and China ($373M).
Imports: In 2019 the top importers of Insulin, in dosage were United States ($2.11B), France ($972M), Germany ($821M), Denmark ($561M), and United Kingdom ($553M).
Tariffs: In 2018 the average tariff for Insulin, in dosage was 3.44%, making it the 5441st lowest tariff using the HS6 product classification.
The countries with the highest import tariffs for Insulin, in dosage are Iran (34.5%), Nepal (15%), Brazil (13.4%), and Argentina (13.4%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ghana (0%), Guinea (0%), and Kenya (0%).
Ranking: Insulin, in dosage ranks 1576th in the Product Complexity Index (PCI).
Description: Insulin is a hormone that is important in the regulation of carbohydrate, fat, and protein metabolism. It is used to treat diabetic patients who have either type 1 or type 2 diabetes, and it is also used to treat the symptoms of diabetes in type 2 patients. It is taken by injection and is used to help glucose enter cells, thus lowering the blood glucose levels.